SAM
UTHR icon

Stenahm Asset Management’s United Therapeutics UTHR Stock Holding History

Stenahm Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$4.17M Hold
19,300
– – 2.72% 17
2021
Q3 		$3.56M Hold
19,300
– – 2.32% 18
2021
Q2 		$3.46M Buy
+19,300
New +$3.68M 2.12% 19

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Stenahm Asset Management's UTHR Position: Q4 2021 in Review

Stenahm Asset Management held its United Therapeutics (UTHR) position steady in Q4 2021 at 19,300 shares worth $4.17M. The position accounts for 2.72% of the portfolio, ranked #17.

Stenahm Asset Management first reported a position in UTHR in Q2 2021 and has held it in 3 quarters since. 416 funds tracked by Wall St. Rank hold UTHR as of Q4 2021.

  • Stenahm Asset Management held 19,300 shares of United Therapeutics worth $4.17M as of Q4 2021.
  • Stenahm Asset Management left its United Therapeutics share count unchanged in Q4 2021.
  • United Therapeutics made up 2.72% of Stenahm Asset Management's portfolio in Q4 2021, its #17 holding.
  • Stenahm Asset Management first reported a position in United Therapeutics in Q2 2021 and has held it in 3 quarters since.
  • 416 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2021.

Based on Stenahm Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.